Clinical Trials Update: May 5, 2006
Hepatitis C Diabetes - Type 2 Bone Metastases
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
People with hepatitis C are sought for a research study of an experimental drug. Candidates must be between 18 and 65 and have never received treatment for hepatitis C (either approved or experimental). Volunteers must be willing to use two methods of birth control throughout the study, must have had a liver biopsy within two years of the start of the study, and must not have significant liver disease in addition to hepatitis C. The research site is in Manhasset, N.Y.
Diabetes - Type 2
This clinical research study will evaluate how effectively type 2 diabetics control their disease. Candidates must be 18-80, have type 2 diabetes, and be controlling their diabetes by exercise or oral medication. Volunteers will receive all medical exams, study-related care and investigational medication at no cost. Compensation up to $750 is available for time and travel. The research site is in Daytona Beach, Fla.
This study will determine how denosumab compares to zoledronic acid to treat bone metastases in people with advanced breast cancer. Candidates must be adults with histologically or cytologically confirmed breast adenocarcinoma with radiographic evidence of at least one bone mets. Additional criteria apply. The research sites are in Atlanta, Ga., and Centrelia, Ill.
Copyright 2006 CenterWatch. All rights reserved.